Highlights from this issue
Share this article
Click the icon of the social media platform on which you would like to share this article.
Email this article to a friend
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Other content recommended for you
- Bell's palsy syndrome: mimics and chameleons
- CIDP: mimics and chameleons
- Unclassified clinical presentations of chronic inflammatory demyelinating polyradiculoneuropathy
- T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy
- CSF sphingomyelin: a new biomarker of demyelination in the diagnosis and management of CIDP and GBS
- Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype
- CIDP presenting as recurrent severe back pain without weakness or sensory loss
- Chronic inflammatory demyelinating polyradiculoneuropathy in solid organ transplant recipients: a prospective study
- Oligoclonal IgG bands in chronic inflammatory polyradiculoneuropathies
- Antibody responses to peptides of peripheral nerve myelin proteins P0 and P2 in patients with inflammatory demyelinating neuropathy